- Home
- / Cellect Biotechnology
Cellect Biotechnology
Cellect Biotechnology Summary
Company Summary
- Overview
- Cellect Biotechnology is a company that develops ApoGraft. It is a platform that functionally selects stem cells in order to improve the efficacy of regenerative medicine and stem cell therapies.
- Type
- Private
- Status
- Closed
- Founded
- 2011
- HQ
- Kefar Sava, IL | view all locations
- Website
- https://www.cellect.co/
- Cybersecurity rating
Table of Contents
Key People
Amos Ofer, COO
Abraham Nahmias, Chairman of the Board
Galina Rodionov, R&D Senior Director
LocationsView all
1 location detected
Kefar Sava, Center District HQ
Israel
HaTa'as St 23, Kefar Sava
Cellect Biotechnology Financials
Summary Financials
- Net income (FY, 2025)
- ($15.8M)
- Cash (FY, 2025)
- $3.8M
- EBIT (FY, 2025)
- ($16.3M)